|
Fem-dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of research supports the oral use of GR-1™ and RC-14 to colonize and protect the vaginal tract.
Clinical trials have shown that GR-1 and RC-14:
- Help to maintain or restore healthy vaginal flora which is important in maintaining vaginal health
- Support the health of the urinary tract
- fem-dophilus is manufactured under pharmaceutical GMP conditions with guaranteed potency and consistency.
The probiotic strains in fem-dophilus are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine.
NOTES: No wheat, no gluten, no soy, no egg, no fish/shellfish, no nuts/tree nuts.
|